The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Research and the Economic “Big One”

Research and the Economic “Big One”

January 1, 2009 • By David S. Pisetsky, MD, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF
David S. Pisetsky, MD, PhD

When I wrote about the EULAR meeting in the September and October issues of The Rheumatologist, I said that times are changing and that rheumatology should be prepared to look carefully at itself and adjust to new realities. In those columns, I focused on the improvement of outcomes in the treatment of rheumatoid arthritis (RA) and how this will change the structure of practice, work force projections, and the research agenda as remission in RA becomes more and more achievable.

You Might Also Like
  • Rheumatology Research Foundation Grants 63 Education, Training, Research Awards
  • ACR Research and Education Foundation Meets with NIAMS and AF to Discuss Funding
  • Rheumatology Research Foundation Reaches 30-Year Milestone
Explore This Issue
January 2009
Also By This Author
  • Your Career’s Election Day

By the calendar, the interval between the EULAR meeting in June and the ACR Annual Scientific Meeting, held in October 2008 in San Francisco, is not a long time, but rather a quick blink in history. Those warm and radiant days on the Champs Élysées, however, now seem like the distant past, shrouded in memory as economic uncertainty swept into our country with the force of a hurricane and flailed everything in its path.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The last few months of financial turmoil and uncertainty have probably been the most momentous for our country since the end of the Second World War, and we are only beginning to learn the magnitude of recent events. There is no Richter scale for historical happenings but, if there was, the time since the financial collapse would certainly rate as a Big One, as earthquake-like changes rattled our entire economy. Even though the ACR meeting provided an outstanding menu of science and learning, everyone could feel the afterstocks of Wall Street’s epic plunges.

Revelations at 30,000 Feet

On the first leg of my flight home from San Francisco, I swiped a copy of the Wall Street Journal (WSJ) that had been left abandoned in the first-class section. To skimp on funds, I, of course, booked the cheapest flight and sat crowded in coach, assailed by the cacophony of a man gripped by sleep apnea and stewing over the $15 baggage fee and the $1 I paid the flight attendant for a cup of bitter, lukewarm coffee. The WSJ was a welcome freebie.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Consider the following headlines of the October 29, 2008, WSJ: “Cash-Poor Biotech Firms Cut Research, Seek Aid”; “Wyeth to Focus Research Efforts on Fewer Diseases”; and “Outlook is Cut for U.S. Drug Sales.”

Those headlines don’t sound particularly good, especially at a time when the pharmaceutical industry provides a significant source of funds for both basic and clinical research. Events at the Moscone Center, San Francisco’s convention hall, may have given a different impression of the state of industry’s health. The exhibit area for the companies was huge, blaring, and boisterous, and filled with the newest in upscale computer displays and advertisements for a cornucopia of products. While the company exhibits were far away from the poster viewing area, many attendees made the trek, interested in seeing what industry had that was new, or perhaps attracted by the “lure of the cappuccino,” as one of my friends said.

Pages: 1 2 3 | Single Page

Filed Under: Opinion, Rheuminations Tagged With: Academia, ACR Scientific Meeting, ResearchIssue: January 2009

You Might Also Like:
  • Rheumatology Research Foundation Grants 63 Education, Training, Research Awards
  • ACR Research and Education Foundation Meets with NIAMS and AF to Discuss Funding
  • Rheumatology Research Foundation Reaches 30-Year Milestone
  • Rheumatology Research Foundation Offers Innovative Research Award for Community Practitioners

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)